MK-0822

DRUG2 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

Hepatic InsufficiencyRenal Insufficiency

Phase 1

Assessment of Pharmacokinetics of Single Dose Odanacatib (MK-0822) in Participants With Moderate Hepatic Insufficiency (MK-0822-070)

CompletedNCT01512693

Merck Sharp & Dohme LLCHepatic Insufficiency

Start: 2012-02-23End: 2012-04-24Updated: 2018-08-29

Pharmacokinetic Assessment of Single-Dose Odanacatib (MK-0822) in Subjects With Severe Renal Insufficiency (MK-0822-067)

CompletedNCT01512667

Merck Sharp & Dohme LLCRenal Insufficiency

Start: 2012-01-17End: 2012-08-22Updated: 2018-08-28